Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 3, 2015, Pages 183-191

  Niu, Zhaoxia ^a,b   Liu, Huaying ^a   Zhou, Ming ^a   Wang, Heran ^a   Liu, Yukun ^a   Li, Xiayu ^c   Xiong, Wei ^a   Ma, Jian ^a   Li, Xiaoling ^a   Li, Guiyuan ^a  

^a HUNAN CANCER HOSPITAL   (China)

^b Henan Engineering College   (China)

^c THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 8F; C Myc; Cdk Rb E2F pathway; Cell growth; Nasopharyngeal carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL PROLIFERATION; DRUG SCREENING; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NASOPHARYNGEAL NEOPLASMS; NUDE MOUSE; ONCOGENE MYC; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; E2F TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84934281235     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu129     Document Type: Article

References (41)

1. FangW, Li X, Jiang Q, Liu Z, Yang H,Wang S, Xie S, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008, 6: 32.
2. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005, 365: 2041-2054.
3. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12: 421-429.
4. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5: 423-428.
5. Faivre S, Janot F, Armand JP. Optimal management of nasopharyngeal carcinoma. Curr Opin Oncol 2004, 16: 231-235.
6. Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 2005, 103: 22-31.
7. Arvanitis C, Felsher DW. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 2006, 16: 313-317.
8. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol 2006, 16: 253-264.
9. Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, Minder JL, et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 2013, 27: 2648-2662.
10. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, et al. Frequent c-Myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 2000, 31: 169-178.
11. Haughey BH, von HD,Windle BE,Wahl GM, Mock PM. c-Myc oncogene copy number in squamous carcinoma of the head and neck. Am J Otolaryngol 1992, 13: 168-171.
12. Hui AB, Lo KW, Teo PM, Huang DP. Genome-wide detection of oncogene amplifications in nasopharyngeal carcinoma by array-based comparative genomic hybridization. Int J Oncol 2002, 20: 467-473.
13. Porter MJ, Field JK, Leung SF, Lo D, Lee JCK, Spandidos DA, van Hasselt CA. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 1993, 114: 105-109.
14. Zheng J, Li WS, Huang RK, Shende L, Zhangling Z. Studies on c-myc gene expression and p16 gene inactivation in nasopharyngeal carcinoma. Chin J Otorhinolaryngol 2000, 35: 464-468.
15. Zhou W, Feng X, Ren C, Jiang X, Liu W, Huang W, Liu Z, et al. Overexpression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Mol Cancer 2013, 12: 53.
16. Wang HB, Liu GH, Zhang H, Xing S,Hu LJ, Zhao WF, Xie B, et al. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma. FEBS J 2013, 280: 2929-2944.
17. Liu H, Zhou M, Luo X, Zhang L, Niu Z, Peng C, Ma J, et al. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc. BMC Mol Biol 2008, 9: 111-125.
18. Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, Wu M, et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010, 31: 559-566.
19. Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, et al. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death Dis 2013, 4: E872.
20. Fellmann C, Lowe SW. Stable RNA interference rules for silencing. Nat Cell Biol 2014, 16: 10-18.
21. Duxbury MS, Matros E, Ito H, Zinner MJ, AshleySW, Whang EE. Systemic siRNA-mediated gene silencing: A new approach to targeted therapy of cancer. Ann Surg 2004, 240: 667-674.
22. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, Zhou M, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosome Cancer 2003, 38: 80-90.
23. Wang YH, Liu S, Zhang G, Zhou CQ, Zhu HX, Zhou XB, Quan LP, et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 2005, 7: R220-R228.
24. Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, Tao Y, et al. Epstein-Barr virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res 2013, 32: 90.
25. Luo WR, Wu AB, Fang WY, Li SY, Yao KT. Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma. Histopathology 2012, 61: 237-246.
26. Zimonjic DB, Popescu NC. Role of DLC1 tumor suppressor gene andMYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics. Int J Oncol 2012, 41: 393-406.
27. Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002, 297: 102-124.
28. Li G, Chang H, Zhai YP, Xu W. Targeted silencing of inhibitors of apoptosis proteins with siRNAs: A potential anti-cancer strategy for hepatocellular carcinoma. Asian Pac J Cancer Prev 2013, 14: 4943-4952.
29. Kabilova TO, Vladimirova AV, Chernolovskaya EL, Vlassov VV. Arrest of cancer cell proliferation by dsRNAs. Ann NY Acad Sci 2006, 1091: 425-436.
30. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras mutations. Nat Med 2001, 7: 235-239.
31. Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002, 296: 1000-1004.
32. Karlsson A, Giuriato S, Tang F, Fung-Weier J, Levan G, Felsher DW. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 2003, 101: 2797-2803.
33. Facchini LM, Penn L. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights. FASEB J 1998, 12: 633-651.
34. Moreno de Alboran I, O'Hagan R, Gartner F, Malynn B, Davidson L, Rickert R, Rajewsky K, et al. Analysis of c-MYC function in normal cells via conditional gene-targeted mutation. Immunity 2001, 14: 45-55.
35. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002, 1: 103-110.
36. Walworth NC. Cell-cycle checkpoint kinases: Checking in on the cell cycle. Curr Opin Cell Biol 2000, 12: 697-704.
37. Hu ZY, Sun J, Zhu XF, Yang D, Zeng YX. ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway. J Transl Med 2009, 7: 74.
38. Amati B, Alevizopoulos K, Vlach J. Myc and the cell cycle. Front Biosci 1998, 3: D250-D268.
39. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 1999, 18: 5321-5333.
40. Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M, Alitalo K. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J 1994, 13: 5442-5450.
41. Shachaf CM, Felsher DW. Tumor dormancy and MYC inactivation: Pushing cancer to the brink of normalcy. Cancer Res 2005, 65: 4471-4474.